Particle.news

Clayface Nears $100M as Low‑Budget DC Horror Outperforms Expectations

Box‑office tallies this week have pushed the R‑rated body‑horror into major milestone territory and raised questions about the commercial case for modestly budgeted, standalone DC films.

Overview

  • Box‑office trackers show Clayface around $98–109 million worldwide depending on the source, with recent tallies reporting roughly $52.0 million domestic and $46.4 million overseas; some social reports claim the film has crossed $100 million but those totals vary by tracker.
  • Industry tallies and story counts say Clayface has already outgrossed Street Fighter worldwide and is within a few million dollars of surpassing The Suicide Squad’s domestic total.
  • Reported production costs for Clayface range near $30–44 million and are often cited at about $40 million, a low figure that helps the film reach break‑even sooner but does not guarantee profit once marketing, exhibitor splits, and downstream revenue are counted.
  • Critics have given the film mixed‑to‑positive notices while audiences have responded strongly, and coverage highlights Tom Rhys Harries’ lead performance and the film’s practical prosthetic effects as central strengths.
  • Analysts say the film’s performance this week could prompt DC Studios to weigh more standalone, genre‑driven projects, but they caution that sustained box‑office holds, stronger overseas legs, and post‑theatrical revenue will determine whether this approach is reliably profitable.